Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2020.00398
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

CD30-targeted Oncolytic Viruses as Novel Therapeutic Approach Against Classical Hodgkin Lymphoma

Oncotarget
Oncology
2018English

Lymphocyte-Rich Classical Hodgkin Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2018English

Circulating Dendritic Cells Deficiencies as a New Biomarker in Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Hemophagocytic Lymphohistiocytosis in a Patient With Classical Hodgkin Lymphoma

Case Reports in Hematology
2016English

An Anaplastic T-Cell Lymphoma Mimicking Classical Hodgkin Lymphoma

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Epigenetic Processes Play a Major Role in B-Cell-Specific Gene Silencing in Classical Hodgkin Lymphoma

Blood
BiochemistryImmunologyCell BiologyHematology
2006English

Suppressor of Cytokine Signaling 1 Gene Mutation Status as a Prognostic Biomarker in Classical Hodgkin Lymphoma

Oncotarget
Oncology
2015English

Novel Therapeutic Agents for Relapsed Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Diffuse Large B-Cell Lymphoma and Classical Hodgkin ́S Lymphoma Converge in an Unusual Presentation as a Gastric Composite Lymphoma: Case Report

Archives of Hematology Case Reports and Reviews
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy